CD177 and apparent mineralocorticoid excess: Frontal-executive and memory dysfunction are well-recognized complications of AME associated with NMDAR and LGI1 autoantibodies, with deficits attributed to changes in the density of cell surface receptors (27–29), brain structure (7, 30), and network integrity (7, 8, 31–33).